搜尋結果
Dosage/Direction for Use. IM Primary vaccination schedule of 2 doses (0.5 mL each): Initial dose followed by 2nd dose 2 mth later. If flexibility in the vaccination schedule is necessary, 2nd dose can be administered between 2 & 6 mth after the 1st dose. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after the ...
Dosage/Direction for Use. 1 tab once daily. Initial therapy: One 150/12.5 mg tab once daily. May be increased after 1-2 wk. Max dose: One 300/25 mg tab once daily as needed to control BP. Click to view CoAprovel detailed prescribing information.
Advanced or unresectable HCC w/ bevacizumab 840 mg every 2 wk, or 1,200 mg every 3 wk, or 1,680 mg every 4 wk, until loss of clinical benefit or unmanageable toxicity. Tecentriq should be administered prior to bevacizumab when given on the same day. Bevacizumab is administered at 15 mg/kg every 3 wk. Click to view Tecentriq detailed prescribing ...
Administer as IV infusion over 60 min. Unresectable stage III NSCLC 10 mg/kg every 2 wk until disease progression, unacceptable toxicity, or max of 12 mth. ES-SCLC 1,500 mg in combination w/ chemotherapy every 3 wk (21 days) for 4 cycles, followed by 1,500 mg every 4 wk as single agent until disease progression or unacceptable toxicity. Patient ...
Tagrisso FC tab 40 mg. Packing/Price. 30's. Form. Tagrisso FC tab 80 mg. Packing/Price. 30's. Tagrisso (Osimertinib mesylate): Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth fac.
Dosage/Direction for Use. IM 2 inj at 2-mth intervals (1 at the age of 2 mth & 1 at the age of 4 mth), followed by 1 booster inj at the age of 11 mth, then another booster inj at the age of 6 yr; booster vaccination for childn 11-13 yr who did not receive a vaccine containing the pertussis valence at normal conc at the age of 6 yr ...
Dosage/Direction for Use. IV 1.25 mg/kg (up to max 125 mg for patients ≥100 kg) infused over 30 min on days 1, 8, & 15 of a 28-day cycle until disease progression or unacceptable toxicity. Click to view Padcev detailed prescribing information.
